Lebwohl M, Strober B, Schrader A, Li A, Eckmann T, Zhu B, Malatestinic W, Birt J, Feely M, Blauvelt A. 6-Month Real World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s232. Available from: https://jofskin.org/33014/index.php/skin/article/view/2337